These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 920413)

  • 21. Effects of dietary linoleic acid on rat platelet ADP-induced aggregation and binding of 125I-fibrinogen.
    McGregor L; Toor B; McGregor JL; Renaud S; Clemetson KJ
    Thromb Res; 1984 Apr; 34(1):75-9. PubMed ID: 6729770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition.
    Fenn CG; Littleton JM
    Thromb Haemost; 1982 Aug; 48(1):49-53. PubMed ID: 6813995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between fatty-acid composition of platelets and platelet aggregation in rat and man. Relation to thrombosis.
    Renaud S; Kuba K; Goulet C; Lemire Y; Allard C
    Circ Res; 1970 May; 26(5):553-64. PubMed ID: 5443133
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet effects of arachidonic acid in dog blood. I. Lack of involvement of cyclo-oxygenase in the in vivo situation.
    Chignard M; Lefort J; Vargaftig BB
    Prostaglandins; 1977 Nov; 14(5):909-27. PubMed ID: 594392
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP; Maguire MH
    Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutrients, platelet function and composition in nine groups of French and British farmers.
    Renaud S; Morazain R; Godsey F; Dumont E; Thevenon C; Martin JL; Mendy F
    Atherosclerosis; 1986 Apr; 60(1):37-48. PubMed ID: 3707672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of varying dietary n-6 to n-3 fatty acid ratios on platelet reactivity, coagulation screening assays, and antithrombin III activity in dogs.
    Boudreaux MK; Reinhart GA; Vaughn DM; Spano JS; Mooney M
    J Am Anim Hosp Assoc; 1997; 33(3):235-43. PubMed ID: 9138234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function.
    Rao GH; Radha E; White JG
    Biochem Biophys Res Commun; 1983 Dec; 117(2):549-55. PubMed ID: 6229254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of dietary linoleic acid level on coagulation, aggregation and fatty acid composition of rats.
    McGregor L; Renaud S
    Nutr Metab; 1977; 21 Suppl 1():192-6. PubMed ID: 917384
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological effects of dietary linoleic acid.
    Vergroesen AJ
    Nutr Rev; 1977 Jan; 35(1):1-5. PubMed ID: 840443
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of dietary linoleic acid on the platelet aggregation, fatty acid composition of platelet phospholipids and synthesis of platelet prostaglandins in rats].
    Markov KhM; Atrokhov VV; Zadkova GF; Pinelis VG; Poleshchuk VS
    Vopr Med Khim; 1988; 34(4):37-41. PubMed ID: 3195130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.
    Lewis GP; Watts IS
    Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rat platelets aggregate in the absence of endogenous precursors of prostaglandin endoperoxides.
    Bult H; Bonta IL
    Nature; 1976 Dec; 264(5585):449-51. PubMed ID: 1004576
    [No Abstract]   [Full Text] [Related]  

  • 39. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
    Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
    Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
    Schafer AI; Adelman B
    J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.